๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies

โœ Scribed by Athanasia Mouzaki; Tibor Diamantstein


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
433 KB
Volume
17
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

โœฆ Synopsis


Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodies* Four new mouse monoclonal antibodies (mAb), ART-38, ART-35, ART-75 and ART-94, directed against the rat interleukin 2 receptor (IL2R) have been developed. As shown by immunoprecipitation' studies they all recognize specifically the 55-kDa subunit of the rat IL 2R. These mAb were compared to three previously characterized mouse mAb directed against the 55-kDa molecule of the rat IL2R, namely the ART-18, ART-65 and OX-39 mAb. Out of all seven mAb, only ART-18 and OX-39 were found to inhibit the IL2 binding to activated T cells, while IL2R inhibited the binding of ART-18 alone. ART-18 was the only mAb found to inhibit the ILZdependent proliferation of cells carrying the IL 2R. Scatchard plot analyses showed gross differences in the numbers of mAb-binding sites ranging between 30000 (ART-65) and 165000 (ART-75) as well as in their affinities which ranged between 2.5 x M (ART-38) and 8.3 x lo-'' M (OX-39). Cross inhibition studies revealed that the mAb recognize four different epitopes on the 55-kDa rat IL2R subunit.


๐Ÿ“œ SIMILAR VOLUMES


Blocking of interleukin 2 (IL 2) binding
โœ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been